Proton Pump Inhibitors A Curate’s Egg? Dr John O’Malley MA MB ChB MRCGP.

Slides:



Advertisements
Similar presentations
Proton Pump Inhibitors
Advertisements

Nursing Care of Patients WithUpper GI Disturbances
Antacids & Acid-Controlling Agents
Drugs Used For Peptic Ulcer
INDIGESTION (DYSPEPSIA) AND HEARTBURN (ACID REFLUX)
Peptic ulcer.
NSAIDs and GI and Renal Complications Lessons from Tennessee Medicaid population studies (and selected others)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen.
Peptic ulcer disease.
DYSPEPSIA Dr.Vishal Rathore. Dyspepsia popularly known as indigestion meaning hard or difficult digestion, is a medical condition characterized by chronic.
Gastroenterology in General Practice. Gastroenterology Dyspepsia Ulcer disease Non-ulcer dyspepsia Helicobacter pylori Altered Bowel Habit Constipation.
Peptic Ulcer Disease Dr. Wael H. Mansy, MD Assistant Professor
DYSPEPSIA Leena Patel 1/2/12. OVERVIEW Statistics Red flags Management H-pylori testing and treatment.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
(H2 blockers and proton pump inhibitors)
Treatment of Common Conditions Kenneth Brummel-Smith, MD Charlotte Edwards Maguire Professor of Geriatrics Florida State University College of Medicine.
Peptic Ulcer Disease. Peptic ulcer  refers to erosion of the mucosa lining any portion of the G.I. tract.  It is defined as : A circumscribed ulceration.
Anti Ulceration and Anti Emetics Nur Irjawati S. Kawang, S.Si,
High Value Care: GERD Sheetal Sharma, MBBS Assistant Professor of Clinical Medicine Associate Director of Endoscopic Quality Section of Advanced Therapeutic.
Gastrointestinal Problems Claire Nowlan MD Jan 16, 2004.
SIGNIFICANT EVENT MEETING – 2 PATIENTS WITH CANCER – 2 PATIENTS WITH CANCER Dr Stephen Newell 8/10/04.
Gastric Acid Secretion 1. Acid synthesis – regulated by 3 transporters Lumen Plasma Parietal cell.
Dyspepsia. What is dyspepsia? ‘pain or discomfort related to eating or drinking that can be attributed to the upper gastro-intestinal tract’
Agents Used to Treat Hyperacidity and Gastroesophageal Reflux Disease
Chapter 24 Agents Used to Treat Hyperacidity and Gastroesophageal Reflux Disease.
N ON - STEROIDAL ANTI - INFLAMMATORY DRUGS. OBJECTIVES At the end of the lecture the students should : Define NSAIDs Describe the classification of this.
1 Prescribing Omissions according to START and related hospital admission in geriatric patients O. Dalleur 1, A. Spinewine 2, S. Henrard 3, C. Losseau.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Pharmacotherapy of Gastric Acidity, Peptic Ulcer…
Peptic Ulcer Disease Dr. Wael H. Mansy, MD Assistant Professor College of Pharmacy King Saud University.
H2 blockers and proton pump inhibitors By Prof. Hanan Hagar.
Gastrointestinal Review Highlights of the VIGOR Trial Lawrence Goldkind M.D.
Update of TARGET ( T reatment a nd R elief of G astroint e s t inal disorder) DR NORITA YASMIN MORNING READ 19/9/13 1.
Clinical features of Upper GI origin More than 4 weeks duration Pain induced or worsened by food 40% of adults have in a life time Generally benign – promote.
NSAID Gastropathy Group B Lim, Imee – Lim, Mary. NSAIDS Weak organic acids that inhibit biosynthesis of prostaglandins Anti-inflammatory, analgesic, antipyretic,
Cimetidine Anatomy Physiology Chemistry Pharmacology Neural effects
Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.
NSAIDs.
The Perils of PPIs How can they harm us? What should they be used for?
Agents Used to Treat Hyperacidity and Gastroesophageal Reflux Disease
Drugs in peptic ulcer (H 2 blockers and proton pump inhibitors) By Prof. Hanan Hagar.
Small Bowel Toxicity of Nonselective NSAIDs Revealed by Capsule Endoscopy: Results From a Pivotal Clinical Trial Glenn M. Eisen, M.D., M.P.H. Associate.
Hot Topic Presentation Lars Halford, GP ST3 March 2010
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
NHS Specialist Pharmacy Service Medicine Use Reviews NSAIDs NHS Specialist Pharmacy Service Medicines Use & Safety.
Upper Gastrointestinal Disorders
HELICOBACTER PYLORI Millions of years old microorganism of mankind Causes a spectrum of diseases Obviously requires high priority Treatment strategies.
S Medicine Use Reviews NSAIDs NHS Specialist Pharmacy Services Medicines Use & Safety P S East & South East England Specialist Pharmacy Services East of.
Joseph J.Y. Sung, MD et al. Am J Gastroenterol 2010;105. R3 김민경.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Medicine Use Reviews NSAIDs NHS Specialist.
Treatment for Upper GI bleeding due to PUD. Goals Control upper GI bleeding Provide symptom relief Promote ulcer healing Prevent recurrence and other.
Non-steroidal anti-inflammatory drugs
NHS Specialist Pharmacy Service NSAIDS – efficacy and safety Expert speaker Slide set Key content from the NPC NSAIDS QIPP slides is gratefully acknowledged.
Clinical Knowledge Summaries CKS Analgesia – mild to moderate pain Prescribing analgesics for mild to moderate pain in adults and children. Educational.
FUNCTIONAL (NON-ULCER) DYSPEPSIA TUCOM Internal Medicine 4th class Dr
Fatimah Abdullah 6th year MS, KFU
PROTON PUMP INHIBITORS (PPI)
Gastroesophageal Reflux Disease affecting the upper gastrointestinal tract. 10% of the population experience Heartburn is the cardinal symptom.
Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Upper Gastrointestinal Cancers Top ⑩ Tips
Drugs for Gastrointestinal and Related Diseases
Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Drugs in peptic ulcer (H2 blockers and proton pump inhibitors)
Mark McAlindon Gastroenterology
מחלות מערכת העיכול.
Can Proton Pump Inhibitor Deprescribing be Undertaken in a Scottish Community Pharmacy Setting? A Feasibility Study. Andrew Christopherson1,2, Alison H.
NSAIDs Epidemiology NSAIDs amounts to 3.8 of all prescriptions
Cologuard Where It Fits In.
Presentation transcript:

Proton Pump Inhibitors A Curate’s Egg? Dr John O’Malley MA MB ChB MRCGP

Meetings, journal, website access ALL FREE !!!!!!!!!!!!!!! Join

This f***ing egg is off!

This is a fantastic drug Why didn’t we realise it has horrendous side effects? It has an important role in treating x

PPIs £1 billion NHS costs Globally £40 Billion

Pharmacology Unstable at acid ph Parietal cell not stomach activation Act by forming a irreversible bond with cysteine residues in the proton pump Short pharmacological half life

Pharmacology 2 But.... Lasts for 24 hours No tachyphylaxis

Text Atropine H 2 Antagonists Proton Pump Inhibitors The Proton Pump

Good bits

Dyspepsia Reflux Barretts/? Prevention of cancer Prevention of strictures Diagnostic test Upper GI bleeding Ulcer prophylaxis in NSAIDs and aspirin Ulceration/ HP eradication Zollinger Ellison Syndrome

And the bad bits?

Side effects Slow response Headaches Rashes Diarrhoea Abdominal pain Flatulence Interactions

Problems Interstitial nephritis Osteoporosis Vitamin B12 absorption C. Diff and other infections Microscopic colitis Inappropriate investigation and referral

And when we should, we don’t

Underuse Gastroprotection Oesophageal strictures ? Barrett’s oesophgus

Gastroprotection

NICE 2001 Recommendations for patients for whom a regular NSAID is absolutely necessary: Patients at any age with existing cardiovascular disease, including patients on low dose aspirin: Standard NSAID e.g. ibuprofen, diclofenac or naproxen +misoprostol or PPI if misoprostol not tolerated. Patients aged 65+ with no cardiovascular risk factors and not onaspirin: Consider Cox-II selective inhibitor (not sure on that one!) All other patients i.e. patients < 65 with no other risk factors*: Standard NSAID e.g. ibuprofen or diclofenac

Risk factors for GI complications with NSAIDs Age Previous ulcer, bleed or perforation Concomitant drug treatment (steroids,anticoagulants, SSRIs) Co-morbidity (CVD, renal and hepatic impairment, etc.) Rheumatoid Arthritis NSAID dosage and duration.

HP eradication Maastricht Chronic NSAID users Naive NSAID users – test and treat Long term aspirin users – test and treat PPI is superior in preventing ulcers

Risk of NSAID related gastrointestinal bleeding by age for population 100,000 Age RangeNumber taking NSAIDNumber with GI bleedRisk in any one year of a GI bleed due to NSAID Risk in any one year of dying from GI bleed due to NSAID in in in 6461 in in 5701 in in 1101 in 647 Anon. Cox-2 roundup. Bandolier 2000;75

ACUTE Vs CHRONIC NSAID USE Drug exposureOR (95%CI) for GUOR (95% CI) for DU Non use11 Acute use4.47 ( )2.39 (1.73 – 3.31) Chronic use2.80 (1.97 – 3.99)1.68 ( )

SSRIs AND UGIH “Our meta-analysis shows that SSRIs more than double the risk of UGIH and concomitant NSAID use increase the risk of UGIH by 500%” Loke et al. Alim. Pharm. Therapeutics 2007

SSRIs: NUMBER NEEDED TO HARM Patient populationBaseline upper GI Event Rate NNH per year with SSRI ( 95% CI) NNH per year with SSRI AND NSAID( 95% CI) Unselected >50 years ( )82 (41-181) No previous ulcer drug use or hospitalisation ( )106 (52-233) Ulcer drug42177 (85-545)46 ( ) Hospitalisation62121 (58 – 370)32 (17-69) Ulcer drug use and hospitalisation ( )19 (10-41)

SSRIs and NSAIDs

Do PPIs work? DrugRisk of UGIB NSAID5.3 Rofecoxib2.1 Paracetamol0.9 NSAID and PPI0.9

Number needed to treat to avoid a peptic ulcer in elderly NSAID/aspirin users

3

Compliance - GPs “In individual studies in primary care adherence to prescribing guidelines varied from 9% to 27%.”

Compliance - patients “...adherence to NSAID plus PPI or H2RA declined rapidly, so that after 6 months the majority of patients were not taking gastroprotection prescribed.” Moore et al. BMC Musculoskeletal Disorders 2006; 7:79

Cost ResourceMean cost £MinimumMaximum Diagnostic endoscopy Therapeutic endoscopy GI opd Surgical procedure Rebleed costs

Omeprazole cost 28 days of 20mg/day =£1.62

Conclusion Right person with the right drug gives the right outcome

Problems Interstitial nephritis Osteoporosis Vitamin B12 absorption C. Diff and other infections Microscopic colitis Inappropriate investigation and referral

Interstitial nephritis

15% of all acute admission with acute kidney damage Immune mediated? Can lead to severe kidney damage Who checks kidney function?

Osteoporosis UK study (GPRD) 13,556 patients with hip fracture Risk 1.4 after using PPI for >1 year Risk 2.65 if long term high dose

Causal? Reduces absorption of dietary calcium Inhibits magnesium absorption Also inhibit osteoclasts ? Prevent osteoporosis Coincidental?

Iron deficiency Iron absorption ? Long term, high dose PPI link Theoretical but not proven

Vitamin B12 Deficiency B12 bound to protein Pepsin needed B12 levels reduced but significant deficiency?

Infections PPI use and Salmonella/ campylobacter

Clostridium Difficile infection Gram positive bacteria Anaerobic spore forming Severe diarrhoea Can lead to pseudomembranous colitis Toxic megacolon Absent gut flora

PPI problems Often taken as antacids Not all reflux is acid Misdiagnosis

50-60% of PPI scripts there is no or an inappropriate reason for prescribing £100 million in the NHS wrongly prescribed £2 billion worldwide Decrease in price but increase use has increased costs PPIs make up 90% of the drug budget for dyspepsia

63%

33%

67%

NICE NICE Guidance 2000 Treat with healing doses then step down Shortest length of treatment with smallest dose No long term use without definitive diagnosis

NICE Dyspepsia Guidelines 2004 Check if PPI needed Lifestyle advice Avoid precipitants Educate Review need

So who do we need to treat more?

Who should we treat more? NSAID Aspirin

And who less?

Rebound hyperacidity Prolonged treatment Increased parietal cell mass Peaks at 2 weeks.

Problems caused Increased use of PPIs Unwillingness to try step down Gastroscopies

Overuse/ wrong use 40% ‘unknown reason’ Mean duration of use 450 days 50% taking drugs that cause or worsen GORD 18% smokers

GORD and effect of medication H2 blockers minutes PPI 24 hours

Step down 42% couldn’t be stepped down 43% reduced need for PPI or changed to antacid/alginate or H2RA 15% stopped completely

Lifestyle

Lifestyle changes Obesity Smoking Raising the head of the bed Decrease fat intake ( chocolate, peppermint, garlic and onions) Large volume meals Rich energy dense meals Low dietary fibre Alcohol decrease

Lifestyle Only reduce severity and frequency Very few patients do it well And some don’t want to

PPIs Used too much Used not enough ‘Lifestyle drug’

Thank you